Literature DB >> 6188418

Right and left isomerism: the cardiac surgeon's view.

C Marcelletti, R Di Donato, A Nijveld, C Squitieri, A H Bulterijs, M Naeff, J Schuller, A E Becker.   

Abstract

We have treated by palliative or corrective surgery 12 patients with the complex cardiovascular anomalies associated with right isomerism (asplenia syndrome) or left isomerism (polysplenia syndrome). A systemic-pulmonary artery shunt was performed in 4 patients, with 2 early deaths. Anatomical intracardiac repair was successfully done in 2 patients, while an orthoterminal repair using a modified Fontan procedure was attempted in 5 patients, only 1 of whom survived. A 1-year-old girl with diffuse pulmonary arteriovenous fistulas associated with left isomerism was not considered a good candidate for operation after an exploratory sternotomy. The surgical options and technical problems related to the complex intracardiac morphology of these developmental syndromes are presented.

Entities:  

Mesh:

Year:  1983        PMID: 6188418     DOI: 10.1016/s0003-4975(10)61592-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Septicaemia and adrenal haemorrhage in congenital asplenia.

Authors:  M P Dyke; R P Martin; P J Berry
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  Outcome of left atrial isomerism at a single institution.

Authors:  Marianne P Eronen; Kristiina A U Aittomäki; Eero O Kajantie; Heikki I Sairanen
Journal:  Pediatr Cardiol       Date:  2012-02-05       Impact factor: 1.655

3.  Management and outcome of infants and children with right atrial isomerism.

Authors:  M Sadiq; O Stümper; J V De Giovanni; J G Wright; B Sethia; W J Brawn; E D Silove
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

4.  Surgical palliation of cardiac malformations associated with right isomerism.

Authors:  T Kawai; Y Wada; T Enmoto; S Nakajima; K Nishiyama; K Kitaura; S Sato; T Oka
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.